Quantitatively, NSE in our PD group (21.57 ± 7.39 ng/mL) was approximately 1.4-fold higher than in hyperglycaemic stroke patients, while concentrations in the T2D group (31.16 ± 4.74 ng/mL) were nearly 1.6-fold greater. The gene discussed is ENO2; the disease is stroke disorder.